Association Between HLA-A*02:07 and Fixed Drug Eruption Caused by Sulfamethoxazole-Trimethoprim

Huyen Tran Thi1, Phuc Nguyen Hoang2, Phuong Pham Thi Minh3

  • 1Department of Dermatology and Venereology, Hanoi Medical University, Hanoi, Vietnam.

PubMed
Abstract

Insights

Fixed drug eruption (FDE) is linked to sulfamethoxazole-trimethoprim. The HLA-A*02:07 allele is associated with developing FDE, suggesting a potential genetic marker for risk assessment.

Area of Science:

  • Pharmacogenomics
  • Immunogenetics
  • Dermatology

Background:

  • Fixed drug eruption (FDE) is a recurring adverse drug reaction.
  • Sulfonamide antibiotics, particularly sulfamethoxazole-trimethoprim, are common triggers for FDE.
  • Human leukocyte antigen (HLA) associations with drug hypersensitivity are increasingly recognized.

Purpose of the Study:

  • To investigate the association between HLA-A alleles and fixed drug eruption (FDE) induced by sulfamethoxazole-trimethoprim.
  • To identify potential genetic markers for sulfamethoxazole-trimethoprim-induced FDE.

Main Methods:

  • A cross-sectional study involving 30 FDE patients and 30 healthy controls.
  • Human leukocyte antigen (HLA)-A typing performed using polymerase chain reaction with sequence-specific oligonucleotides (PCR-SSO).

Main Results:

  • The HLA-A*02:07 allele was significantly more frequent in FDE patients (40%) compared to controls (16.67%, p < 0.05).
  • Individuals with the HLA-A*02:07 allele had a 3.33-fold increased likelihood of developing FDE from sulfamethoxazole-trimethoprim.
  • No significant differences in other HLA-A allele frequencies were observed between groups.

Conclusions:

  • An association exists between the HLA-A*02:07 allele and fixed drug eruption (FDE) caused by sulfamethoxazole-trimethoprim in the Vietnamese population.
  • Pre-prescription screening for HLA-A*02:07 may help identify individuals at risk for FDE.

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
983
Phase II Reactions: Sulfation and Conjugation with &#945;-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
435
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
242
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.8K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
679